Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2024-12-06 Director's Dealing
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo S.p.A. - Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Oggetto: Farmacosmo S.p.A. - Internal Dealing' and contains a 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate.' This structure and content explicitly describe a report of personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). The document is a formal notification template, not just an announcement of a report, and it contains the substantive details of the dealing, even if the transaction details themselves are in an attachment ('Vedi allegato'). Given the length (over 80k characters) and the presence of the full template structure, it is classified as the filing itself, not an RPA.
2024-12-06 Italian
Farmacosmo S.p.A. - Internal Dealing
Director's Dealing Classification · 100% confidence The document is titled 'Oggetto: Farmacosmo S.p.A. - Internal Dealing' and includes the template 'Modello di notifica e di comunicazione al pubblico delle operazioni effettuate da persone che esercitano funzioni di amministrazione, di controllo o di direzione e da persone a loro strettamente associate' (Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them). This content directly corresponds to the reporting requirements for insider transactions by directors and executives, which maps to the Director's Dealing category.
2024-12-06 Italian
Farmacosmo Conferma La Traiettoria Di Crescita Sul Canale Retail Anche Grazie Al Portale Proprietario Baucosmesi.It
Earnings Release Classification · 98% confidence The document is a press release ('COMUNICATO STAMPA') from Farmacosmo S.p.A. dated October 28, 2024. The subject matter explicitly states that the Board of Directors reviewed certain consolidated management data (revenues and key business KPIs) as of September 30, 2024. It provides key financial highlights (Revenues, Retail vs B2B breakdown) for the first nine months of the year. This structure—a formal announcement of preliminary, non-audited financial results for a specific interim period (9 months ending Sept 30)—is characteristic of an Earnings Release (ER). While it contains more detail than a typical US earnings release, the primary function is the initial disclosure of period results, not the comprehensive, audited report (10-K or IR). It is not a transcript (CT), a full annual report (10-K), or a formal audit report (AR). Therefore, it is classified as an Earnings Release (ER). 9M 2024
2024-10-28 Italian
Esercizio Da Parte Di Laboratorio Farmaceutico Erfo Opzione Di Vendita Del 49% Di FRCM1 S.r.l. (FarmaWoW.It) Al Socio Di Maggioranza Farmacosmo S.p.A.
M&A Activity Classification · 99% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and details a specific corporate action: the exercise of a put option by Laboratorio Farmaceutico Erfo to sell its 49% stake in FRCM1 S.r.l. back to the majority shareholder, Farmacosmo S.p.A. This is a material event disclosure concerning a change in shareholding/transaction structure, but it is not a standard periodic report (like 10-K or IR) nor a general regulatory filing (RNS). It is a specific announcement about a transaction involving shares/capital structure, but the core event is the execution of a pre-agreed transaction, which often falls under general corporate news or transaction announcements. Given the options, this is a specific corporate event announcement. Since it details a transaction involving the acquisition/sale of a stake, it relates to capital structure changes or significant transactions. However, the most fitting general category for a press release announcing a specific corporate event that isn't a dividend, earnings, or management change is often a Regulatory Filing (RNS) if no better fit exists, or potentially Capital/Financing Update (CAP) if the transaction is viewed primarily as a capital restructuring. Since the document explicitly states 'Vedi allegato' (See attachment) and is structured as a formal press release announcing a specific transaction outcome, it functions as a regulatory disclosure. Given the options, and since it's not a standard financial report, 'RNS' (Regulatory Filings - general fallback for miscellaneous filings) is appropriate, although 'TAR' (M&A Activity) might be considered if this were a merger, which it is not. It is a specific transaction announcement. In the context of Italian regulatory filings (where REGEM is used), this type of specific transaction disclosure is often categorized broadly. I will classify it as RNS as it is a formal, non-standard disclosure announcement, fitting the 'miscellaneous' criteria better than the specific transaction codes provided, which lean towards M&A or share buybacks (POS). The document length (7061 chars) is substantial enough that it is the report itself, not just a notification of a report (ruling out RPA).
2024-10-25 Italian
Farmacosmo: Il Consiglio Di Amministrazione Approva La Relazione Finanziaria Semestrale Consolidata Al 30 Giugno 2024
Earnings Release Classification · 95% confidence The document is a press release issued by Farmacosmo S.p.A. announcing the approval of its consolidated half-year financial report as of June 30, 2024. It provides key financial highlights (revenue, EBITDA, net result, PFN) and management commentary on business performance. While it contains substantive financial data, it is structured as a corporate press release (Earnings Release) rather than the full statutory interim report itself. According to the filing definitions, an initial announcement of periodical financial results is classified as an Earnings Release (ER). H1 2024
2024-09-27 Italian
Perfezionato Il Conferimento Del Ramo D’azienda ‘Logistcs’ In Favore Di Farmacosmo Logistics S.r.l.
Regulatory Filings Classification · 95% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and details a specific corporate action: the finalization of the contribution of the 'Logistics' business unit into a newly formed subsidiary, Farmacosmo Logistics S.r.l. This type of announcement, detailing a significant structural or operational change (like a spin-off or business unit transfer), is a material event that requires immediate disclosure to the market. It is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A). Since it is a specific, material corporate announcement that doesn't fit the highly specific categories like M&A (TAR) or Director's Dealing (DIRS), it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is a formal disclosure made via the regulated information service (as indicated by 'Informazione Regolamentata'). The document itself is the announcement, not a report attached to an announcement, so RPA is less appropriate than RNS for this type of material event disclosure.
2024-08-01 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.